Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1390777 NEW YORK, NY
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$3,426,189
+$1,163,329 QoQ
Shares Held
82,222
+13.7% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 159 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. RAPP ranks #120 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in RAPP

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,426,189 82,222
2026-03-31 $2,262,860 72,319
2025-12-31 $2,247,616 74,081
2025-09-30 $1,408,432 47,422
2025-06-30 $455,981 40,104
2025-03-31 $355,884 35,482
2024-12-31 $354,231 19,968
2024-09-30 $408,985 19,970